| Absorption |
| Blood-Brain Barrier | BBB+ | 0.6845 |
| Human Intestinal Absorption | HIA- | 0.5631 |
| Caco-2 Permeability | Caco2- | 0.8963 |
| P-glycoprotein Substrate | Non-substrate | 0.6976 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9659 |
| Non-inhibitor | 0.9610 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9481 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7088 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8646 |
| CYP450 2D6 Substrate | Non-substrate | 0.8899 |
| CYP450 3A4 Substrate | Non-substrate | 0.7305 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9220 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9463 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9450 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9572 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9105 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9892 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9903 |
| Non-inhibitor | 0.9474 |
| AMES Toxicity | Non AMES toxic | 0.9327 |
| Carcinogens | Non-carcinogens | 0.8485 |
| Fish Toxicity | Low FHMT | 0.7127 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.9771 |
| Honey Bee Toxicity | High HBT | 0.6025 |
| Biodegradation | Ready biodegradable | 0.9832 |
| Acute Oral Toxicity | IV | 0.4722 |
| Carcinogenicity (Three-class) | Non-required | 0.8080 |